Prenatal diagnosis of trisomy 8 mosaicism, initially identified by cffDNA screening
Abstract Background So called cell-free fetal DNA (cffDNA) in the maternal plasma, which is derived from placenta, is widely used to screen fetal aneuploidies, including trisomy 21, 18, 13 and sex chromosomes. Here we reported a case of trisomy 8 mosaicism (T8M), which was initially identified via c...
Main Authors: | Junjie Hu, Kai Yan, Pengzhen Jin, Yanmei Yang, Yixi Sun, Minyue Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Molecular Cytogenetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13039-022-00616-y |
Similar Items
-
Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling
by: Agnese Feresin, et al.
Published: (2022-10-01) -
CffDNA screening for Niemann–pick disease, type C1: a case series
by: Sydney A. Lau, et al.
Published: (2024-08-01) -
The significance of trisomy 7 mosaicism in noninvasive prenatal screening
by: Yiming Qi, et al.
Published: (2019-04-01) -
The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis
by: J. C. Bayón, et al.
Published: (2019-03-01) -
Diagnóstico prenatal no invasivo
by: DR. L. Sebastián Illanes, et al.
Published: (2014-11-01)